Clinical Trial Update: Busulfan and Cyclophosphamide Followed By ALLO BMT [NA]

View source ↗

Summary

Clinical trial update for busulfan and cyclophosphamide followed by allogeneic stem cell transplant in acute leukemias; study is terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Allogeneic stem cell transplantation
• BUSULFAN (Busulfan)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | NA | Status: TERMINATED | Results posted: 2021-04-13